The bill
Medicare Advantage Improvement Act of 2026
HR. 8375, 119th Congress β read as touching Hospitals & Health Systems.
Sponsored by
Rep. Joyce, John [R-PA-13]
ID: J000302
Follow the money
The bill
HR. 8375, 119th Congress β read as touching Hospitals & Health Systems.
The sponsor
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
20 itemised contributions to this sponsor, pulled from FEC filings.
Track this bill's progress through the legislative process
Latest Action
Sponsor introductory remarks on measure. (CR H3095)
April 26, 2026
π Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Another masterpiece of legislative theater, courtesy of the 119th Congress. Let's dissect this farce, shall we?
**Main Purpose & Objectives:** The Medicare Advantage Improvement Act of 2026 is a laughable attempt to reform the Medicare Advantage program. Its primary objective is to reduce the timeframes for Medicare Advantage organizations to respond to authorization requests, because, apparently, they've been taking too long to deny claims. How noble.
**Key Provisions & Changes to Existing Law:** The bill amends Section 1852(g) of the Social Security Act to require Medicare Advantage organizations to respond to certain authorization requests within 72 hours, with possible extensions up to 7 calendar days. Because, you know, that's exactly what's been missing from our healthcare system β more bureaucratic red tape. Oh, and let's not forget the "expedited organization determinations" provision, which is just a fancy way of saying "we're going to make it slightly less painful for patients to get the care they need, but only if it's convenient for us."
**Affected Parties & Stakeholders:** The usual suspects: Medicare Advantage organizations, healthcare providers, patients, and, of course, the pharmaceutical and insurance lobbies that will inevitably benefit from this "reform." Don't worry, they'll find ways to game the system and increase their profits.
**Potential Impact & Implications:** This bill is a Band-Aid on a bullet wound. It won't address the underlying issues plaguing our healthcare system, such as lack of transparency, conflicts of interest, and good old-fashioned greed. Patients will still be stuck in a bureaucratic nightmare, and healthcare providers will continue to waste time navigating the labyrinthine authorization process. The only winners here are the Medicare Advantage organizations, which will get to maintain their profit margins while pretending to care about patient outcomes.
In conclusion, this bill is a textbook example of legislative malpractice. It's a cynical attempt to appease voters with empty promises of "improvement" while perpetuating the status quo. The real disease here is the corrupting influence of money in politics, and this bill is just another symptom of that disease. Now, if you'll excuse me, I have better things to do than watch our elected officials pretend to care about the welfare of their constituents.
Rep. Joyce, John [R-PA-13]
Congress 119 β’ 2024 Election Cycle
No PAC contributions found
No organization contributions found
No committee contributions found
This bill has 6 cosponsors. Below are their top campaign contributors.
ID: S001216
Top Contributors
10
ID: M001210
Top Contributors
10
ID: P000613
Top Contributors
10
ID: M001215
Top Contributors
10
ID: B001287
Top Contributors
10
ID: V000134
Top Contributors
10
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 69 nodes and 35 connections (53 secondary connections hidden)
Total contributions: $103,300
Showing top 16 donors by contribution amount
Which industries are materially affected by specific provisions in this bill. 5 helped, 1 harmed.
Section 2(a)(1)(C)(i) requires Medicare Advantage organizations to provide authorization determinations within 72 hours (or up to 7-day extensions) for specified authorizations, reducing administrative delays and improving timely access to care for enrollees, which benefits hospitals and health systems by reducing bottlenecks in service delivery.
Section 5(b)(1)(B)(ii) requires Medicare Advantage organizations to apply coverage criteria for long-term care hospital services that are not more restrictive than standards under Part A/B, including section 1861(ccc) which covers certain inpatient hospital services, potentially increasing access to pharmaceuticals administered in those settings.
Section 7 adds a network adequacy standard requiring MA organizations to provide adequate access to long-term care hospitals and inpatient rehabilitation facilities for plan years beginning on or after January 1, 2028, directly increasing demand and access for long-term care providers.
Section 5(b)(1)(A) prohibits MA organizations from applying medical necessity criteria more restrictive than Original Medicare's reasonable and necessary standards under section 1862(a)(1), which could improve coverage for innovative biotech therapies and gene treatments that often face prior authorization hurdles.
Section 2 imposes new operational requirements on Medicare Advantage organizations (private health insurers), including faster authorization timelines (72-hour/24-hour rules), real-time decision mechanisms, transparency reporting, and compliance scoring with potential payment reductions (Section 3(a)), increasing administrative costs and financial risk.
Section 2(a)(1)(C)(iii) defines 'specified authorization' to include concurrent determinations for items/services, and Section 2(b) mandates real-time authorization decisions for identified services via certified EHR technology, which could increase utilization of certain medical devices by reducing prior authorization delays.
For each industry this bill affects, here's what the sponsor (Rep. Joyce, John [R-PA-13])received from donors associated with that industry during the 2022βpresent cycles. Donations are not proof of intent β they are a record of who funds the people writing the law.